Concepedia

Publication | Open Access

Phase II study of olaparib (O) and durvalumab (D) (MEDIOLA): Updated results in patients (pts) with germline BRCA-mutated (gBRCAm) metastatic breast cancer (MBC)

DOIFull Paper Access

50

Citations

0

References

2019

Year

Susan M. Domchek, S. Postel-Vinay, S.-A. Im, Y.H. Park, J.P. Delord, Antoîne Italiano, Jérôme Alexandre, Benoît You, Sara Bastian, Matthew Krebs,
Annals of Oncology

No additional data available for this publication yet. Check back later!